Position in AZN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$3,592,107,491
New position
Shares Held
18,213,708
first reported quarter
Ownership
1.17%
of shares outstanding
% of Portfolio
2.95%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 97.15042099060773.ToString("F0")%
Shared 0.ToString("F0")%
None 2.8495790093922664.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026PRIMECAP MANAGEMENT CO/CA/ holds $21,974,718,946 across 9 Drug Manufacturers - General names. AZN ranks #2 (16.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,223,432 | $8,483,436,050 | |
| 2 | AZN |
Astrazeneca PLC
This page
|
18,213,708 | $3,592,107,491 | |
| 3 | AMGN |
Amgen Inc
|
8,874,129 | $3,122,362,288 | |
| 4 | BIIB |
Biogen Inc.
|
14,757,607 | $2,705,512,091 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
24,985,149 | $1,515,349,286 | |
| 6 | GSK |
GSK plc
|
25,204,538 | $1,391,038,452 | |
| 7 | NVS |
Novartis AG
|
7,567,354 | $1,155,913,323 | |
| 8 | SNY |
Sanofi
|
97,168 | $4,681,554 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,592,107,491 | 18,213,708 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||